Senores Pharma US arm ropes in Gautam Shah as President of US Operations
Ahmedabad: Senores Pharmaceuticals Limited's U.S. subsidiary, Havix Group Inc. D/B/A Aavis Pharmaceuticals, has announced the appointment of Gautam Shah as President of U.S. Operations.
Shah brings over three decades of experience in the pharmaceutical industry, including 10 years in India and 20 years in the United States. His illustrious career includes senior roles at renowned pharmaceutical companies such as Cipla and Sun Pharma in India and Sun Pharma, Zydus Lifesciences, Intas Pharmaceuticals, Dow Corning Corp., and Med-Pharmex in the U.S. His expertise spans quality assurance, compliance, operations management, manufacturing, and leadership.
Shah holds a bachelor's degree in pharmacy, a postgraduate diploma in business administration, and is a certified Six Sigma Black Belt.
"As President of US Operations, he will lead our entire group’s US operations and will be instrumental in future expansion," the company stated in a release.
Senores Pharmaceuticals Limited is a global, research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the US, Canada, and other regulated and emerging markets across various therapeutic areas and dosage forms. The companies’ current portfolio includes 61 ANDA and 22 CMO/CDMO commercial products that are permitted for distribution in the USA. Senores is also engaged in the development and manufacturing of complex generics certified by global food and drugs authorities and delivers generic drugs for emerging markets catering to more than 40 countries. The company has currently approval from regulatory bodies of more than 10 countries for its manufacturing facility in Chhatral for emerging markets with over 260 product registrations and 530 product applications. Senores also manufactures critical care injectables and Active Pharmaceutical Ingredients (“API”). Senores has 2 manufacturing facilities for formulations – one in Atlanta, US which is USFDA approved and DEA, TAA & BAA compliant for controlled substances and government supplies & other is in Chhatral, Ahmedabad, India approved by WHO-GMP to cater to emerging markets. The company also has 2 manufacturing facilities for API in India, both located around Ahmedabad, with one in Chhatral and the other in Naroda.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.